Literature DB >> 16475901

CYP2C8 polymorphism among the Portuguese.

Isa Cavaco1, Rita Piedade, J Pedro Gil, Vera Ribeiro.   

Abstract

Cytochrome P450 2C8 (CYP2C8) is a polymorphic phase I drug-metabolising enzyme involved in the metabolism of a wide variety of xenobiotics, as well as a proposed player in the regulation of vascular tone. Polymorphisms in this gene may have an impact on the metabolism of therapeutic drugs such as paclitaxel and verapamil. In this report we have determined the frequencies of the main non-synonymous CYP2C8 alleles, 805A>T (CYP2C8*2), 416G>A/1196A>G (CYP2C8*3) and 792C>G (CYP2C8*4) in a sample representative of Portuguese Caucasians. The allelic frequencies determined were 1.2%, 19.8%, and 6.4% for CYP2C8*2, CYP2C8*3, and CYP2C*4, respectively. The observed CYP2C8*3 prevalence is significantly different from the frequencies previously reported in North European populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475901     DOI: 10.1515/CCLM.2006.030

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.

Authors:  P Dorado; I Cavaco; M C Cáceres; R Piedade; V Ribeiro; A Llerena
Journal:  Eur J Clin Pharmacol       Date:  2008-06-12       Impact factor: 2.953

2.  Frequencies of Cytochrome P450 2B6 and 2C8 Allelic Variants in the Mozambican Population.

Authors:  Paulo Arnaldo; Ricardo Estevão Thompson; Márcia Quinhones Lopes; Philip Noel Suffys; Adalberto Rezende Santos
Journal:  Malays J Med Sci       Date:  2013-07

3.  Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent.

Authors:  Guilherme Suarez-Kurtz
Journal:  Eur J Clin Pharmacol       Date:  2010-10-03       Impact factor: 2.953

4.  Variability of CYP2C8 Polymorphisms in Three Jordanian Populations: Circassians, Chechens and Jordanian-Arabs.

Authors:  Sara Abudahab; Nancy Hakooz; Nuha Tobeh; Esraa Gogazeh; Munir Gharaibeh; Laith Al-Eitan; Malek Zihlif; Rana Dajani
Journal:  J Immigr Minor Health       Date:  2021-08-26

5.  Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment.

Authors:  Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Mårtensson; Jose Pedro Gil
Journal:  Pharmgenomics Pers Med       Date:  2020-11-12

6.  Pharmacogenomic assessment of Mexican and Peruvian populations.

Authors:  Sharon Marsh; Cristi R King; Derek J Van Booven; Jane Y Revollo; Robert H Gilman; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

Review 7.  CYP2C8 and antimalaria drug efficacy.

Authors:  J P Gil; E Gil Berglund
Journal:  Pharmacogenomics       Date:  2007-02       Impact factor: 2.533

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.